Home
About
FAQ
History (14)
Organ Transplantation
Prostaglandins H
Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502.
Pelvic Inflammatory Disease
Abortion, Therapeutic
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Error
An application error has occurred
This error has been logged to the server event log and should be reviewed.
Error Message: